School of Dentistry, Federal University of Pará, Augusto Correa Av, No 1, Guamá, Belém, Pará, 66075-110, Brazil.
Department of Restorative Dentistry, Araraquara Dental School, Sao Paulo State University, Araraquara, SP, Brazil.
Lasers Med Sci. 2022 Sep;37(7):2791-2804. doi: 10.1007/s10103-022-03578-0. Epub 2022 May 21.
The authors aimed to conduct a systematic review to assess data from the current literature on the effectiveness of low-level laser therapy (LLLT) in preventing tooth sensitivity (TS) after tooth whitening (DB). PRISMA guidelines for systematic reviews were followed. Clinical trials evaluating the treatment of LLLT in patients with sensitivity after tooth whitening were selected. A full bibliographic search was performed on May 4, 2021, in the following databases: Embase, MEDLINE via PubMed, SciELO, VHL Regional Portal, Web of Science, Gray Literature, Scopus, ClinicalTrials.gov and Cochrane Library. This study followed Cochrane's recommendations for analyzing risk of bias. A total of 1054 studies were found (255 studies were excluded because they were duplicates and 785 because of titles and abstracts). Only 14 articles were selected for analysis, of which eight were excluded because they had one or more exclusion criteria, resulting in six articles included in this systematic review, the vast majority being classified as low risk of bias. The studies reviewed indicated that LLLT showed promise in preventing TS after TB. However, evidence is limited and more clinical trials with low risk of bias are needed to reach a definitive conclusion on the action of LLLT in pain control after TB.
本研究旨在通过系统评价评估当前关于低水平激光疗法(LLLT)预防牙齿美白(DB)后牙齿敏感(TS)的有效性的数据。本研究遵循 PRISMA 系统评价指南。纳入了评价 LLLT 治疗牙齿美白后敏感性患者的临床试验。于 2021 年 5 月 4 日在以下数据库中进行了全面的文献检索:Embase、MEDLINE 通过 PubMed、SciELO、VHL 区域门户、Web of Science、灰色文献、Scopus、ClinicalTrials.gov 和 Cochrane Library。本研究遵循 Cochrane 分析偏倚风险的建议。共发现 1054 项研究(255 项研究因重复而被排除,785 项因标题和摘要而被排除)。仅选择了 14 篇文章进行分析,其中 8 篇因存在一个或多个排除标准而被排除,因此本系统评价纳入了 6 篇文章,其中绝大多数被归类为低偏倚风险。综述的研究表明,LLLT 在预防 TB 后 TS 方面具有一定前景。然而,证据有限,需要更多低偏倚风险的临床试验才能对 LLLT 在 TB 后疼痛控制方面的作用得出明确结论。